Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
22
BTMD Quote, Financials, Valuation and Earnings
Last price:
$2.57
Seasonality move
:
9.59%
Day range:
$2.55 - $2.68
52-week range:
$2.32 - $6.03
Dividend yield:
0%
P/E ratio:
3.25x
P/S ratio:
0.47x
P/B ratio:
--
Volume:
125.7K
Avg. volume:
137.7K
1-year change:
-56.2%
Market cap:
$79.2M
Revenue:
$197.2M
EPS (TTM):
$0.79
Analysts' Opinion
-
Consensus Ratingbiote Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.21, biote Corp. has an estimated upside of 63.26% from its current price of $2.58.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.00 representing -16.28% downside risk from its current price of $2.58.
Fair Value
-
According to the consensus of 5 analysts, biote Corp. has 63.26% upside to fair value with a price target of $4.21 per share.
BTMD vs. S&P 500
-
Over the past 5 trading days, biote Corp. has overperformed the S&P 500 by 2.84% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
biote Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
biote Corp. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter biote Corp. reported revenues of $48M.
Earnings Growth
-
biote Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter biote Corp. reported earnings per share of $0.22.
Enterprise value:
205.3M
EV / Invested capital:
--
Price / LTM sales:
0.47x
EV / EBIT:
5.01x
EV / Revenue:
1.05x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
5.96x
Price / Operating cash flow:
2.67x
Enterprise value / EBITDA:
4.58x
Gross Profit (TTM):
$138M
Return On Assets:
28.82%
Net Income Margin (TTM):
16.59%
Return On Equity:
--
Return On Invested Capital:
50.14%
Operating Margin:
18.12%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $184.1M | $193.1M | $195.6M | $51.4M | $48M | |
| Gross Profit | $122.8M | $131.1M | $138M | $35.4M | $33.7M | |
| Operating Income | $30.5M | $41.2M | $41M | $13M | $8.7M | |
| EBITDA | $32.6M | $45.2M | $44.8M | $13.8M | $9.6M | |
| Diluted EPS | -$0.37 | $0.12 | $0.79 | $0.33 | $0.22 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $100.8M | $117.8M | $70M | $57.1M | |
| Total Assets | -- | $109.6M | $149.7M | $101.3M | $111.3M | |
| Current Liabilities | -- | $22.4M | $25.1M | $46.5M | $56.3M | |
| Total Liabilities | -- | $180.4M | $201M | $228.1M | $176.8M | |
| Total Equity | -- | -$70.8M | -$51.3M | -$126.8M | -$65.5M | |
| Total Debt | -- | $119.7M | $116M | $121.8M | $146.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $26M | $39.8M | $40M | $15.6M | $14.1M | |
| Cash From Investing | -$22M | $1.5M | -$5.8M | -$2M | -$690K | |
| Cash From Financing | -$15.8M | -$68.7M | -$44.4M | -$1.8M | -$4.9M | |
| Free Cash Flow | $24M | $33M | $34.4M | $13.6M | $13.4M | |
BTMD
Sector
Market Cap
$79.2M
$28.3M
Price % of 52-Week High
42.79%
51.99%
Dividend Yield
0%
0%
Shareholder Yield
-3.85%
-1.59%
1-Year Price Total Return
-56.2%
-17.41%
Beta (5-Year)
--
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$2.53
200-day SMA
Sell
Level
$3.31
Bollinger Bands (100)
Sell
Level
2.58 - 3.18
Chaikin Money Flow
Sell
Level
-4.6M
20-day SMA
Sell
Level
$2.64
Relative Strength Index (RSI14)
Sell
Level
47.97
ADX Line
Sell
Level
16.96
Williams %R
Neutral
Level
-55.914
50-day SMA
Sell
Level
$2.64
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
10.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2629)
Sell
CA Score
(Annual)
Level (-3.0962)
Buy
Beneish M-Score
(Annual)
Level (-3.8522)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-22.8971)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.
Stock Forecast FAQ
In the current month, BTMD has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The BTMD average analyst price target in the past 3 months is $4.21.
-
Where Will biote Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that biote Corp. share price will rise to $4.21 per share over the next 12 months.
-
What Do Analysts Say About biote Corp.?
Analysts are divided on their view about biote Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that biote Corp. is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is biote Corp.'s Price Target?
The price target for biote Corp. over the next 1-year time period is forecast to be $4.21 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is BTMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for biote Corp. is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BTMD?
You can purchase shares of biote Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase biote Corp. shares.
-
What Is The biote Corp. Share Price Today?
biote Corp. was last trading at $2.57 per share. This represents the most recent stock quote for biote Corp.. Yesterday, biote Corp. closed at $2.58 per share.
-
How To Buy biote Corp. Stock Online?
In order to purchase biote Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BTMD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BTMD
Sector
P/E ratio
3.25x
24.24x
PEG ratio
0.01x
-0.01x
P/B ratio
--
1.84x
Price / LTM sales
0.47x
1.60x
Growth Metrics
BTMD
Sector
Revenue growth
-6.67%
4.6%
Earnings growth
-32.77%
10.71%
Revenue (5-year growth)
12.39%
6.45%
Earnings forecast
$0.10
-$0.19
Profitability
BTMD
Sector
Profitability FY 2024
$135.5M
$3.5M
Return on invested capital
50.14%
-32.04%
Return on assets
28.82%
-28.44%
Return on equity
--
-38.09%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
11
Estimated Next Earnings Date
Feb
4
Balance Sheet
BTMD
Sector
Total cash
$28M
$26.1M
Short term investments
--
$25.7M
Total assets
$122.4M
$76.4M
Long term debt
$146.3M
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
